TrialGlobe

Sponsor

Clinical trials sponsored by Columbia University

Active studies whose public registry record names Columbia University as lead sponsor.

15active studies
12recruiting now
2countries represented
5largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Insulin Resistance, HyperinsulinemiaCondition
Insulin regular, 2.0-3.2 mU/m2/min (euinsulinemia), Insulin regular, 32 mU/m2/min (hyperinsulinemia)Treatment
United States1 locations
Columbia UniversitySponsor
Updated 2026-09-08 · NCT06592261See eligibility →
Recruiting nowPhase 1

Alpelisib Challenge Test (ACT)

Insulin Resistance, Type 2 DiabetesCondition
Alpelisib 300 mg, Alpelisib Challenge Test (ACT): Mixed Meal Tolerance Test (MMTT) after taking alpelisibTreatment
United States1 locations
Columbia UniversitySponsor
Updated 2026-09-03 · NCT07778524See eligibility →

Related sponsors

Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.